Kezar Life Sciences, Inc. (KZR) Receivables - Other (2023 - 2025)

Kezar Life Sciences (KZR) posted Receivables - Other of $1.7 million for Q4 2025, little changed sequentially from $1.7 million in Q3 2025.

Kezar Life Sciences, Inc. (KZR) Receivables - Other (2023 - 2025) Analysis & Trends

Kezar Life Sciences has reported Receivables - Other for 2 years, with the latest figure at $1.7 million in Q4 2025.

Quarterly Receivables - Other changed N/A year-over-year to $1.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.7 million (changed N/A YoY) and the FY2025 annual result came in at $1.7 million, changed N/A from the prior year.
Receivables - Other held at $1.7 million in Q4 2025 per KZR's latest filing, from $1.7 million in the prior quarter.
Over five years, Receivables - Other peaked at $1.7 million in Q1 2025 and troughed at $695000.0 in Q4 2023.

Download Data